Dr. K K Talwar

Dr. K K Talwar

Chairman

52 Years of Experience

Interventional Cardiologist

MBBS, MD, DM, FACC

Reg. No.:63389, Delhi Medical Council

Confirm Your Consultation With Dr. K K Talwar

Expert Help When You Need It – Plan in 60 Minutes

About Dr. K K Talwar

  • Dr. Kewal Kishan Talwar is a distinguished Interventional Cardiologist with over 52 years of clinical experience.
  • He pioneered the first Implantable Cardioverter-Defibrillator (ICD) therapy in South Asia, recognized by the LIMCA Book of Records, 1997.
  • He introduced Cardiac Resynchronization Therapy in India, also listed in the LIMCA Book of Records.
  • Dr. Talwar played a key role in developing cardiac arrhythmia as a specialty and established the Heart Failure and Transplant program at AIIMS.
  • He previously served as Head of Cardiology at AIIMS, New Delhi, and Director of PGIMER, Chandigarh.
  • He has held prominent leadership positions, including Chairman of the Medical Council of India and President of the National Academy of Medical Sciences.
  • He is a Fellow of the American College of Cardiology, Indian National Science Academy, and several other prestigious institutions.
  • His prolific academic contributions include 240 published articles, 270 abstracts, and 15 textbook chapters.
  • He has led and participated in numerous professional societies, including the Heart Rhythm Society of India and Heart Failure Society of India.

Confirm Your Consultation With Dr. K K Talwar

Expert Help When You Need It – Plan in 60 Minutes

Education

  • MBBS, Punjab University, 1973
  • MD (Medicine), Postgraduate Institute of Medical Education and Research, Chandigarh, 1976
  • DM (Cardiology), Postgraduate Institute of Medical Education and Research, Chandigarh, 1989
  • Fellow of the American College of Cardiology (FACC)

OPD Schedule Of Dr. K K Talwar

Book Appointment

Past Experience

  • Consultant, St. Stephens Hospital, 2016
  • Chairman, Max Super Specialty Hospital, Saket,
  • Director, Postgraduate Institute of Medical Education and Research, Chandigarh
  • Aryabhat Award, 2012
  • Padma Bhushan, 2006
  • B.C Roy Award, 2000
  • Ranbaxy Research Award, 1997
  • Amrut Mody Unichem Award, 1993
  • Shyamlal Saksena Award From the National Academy of Medical Sciences, 1988
  • Searle Award, 1987
  • Prof. Sujoy B. Roy Memorial Investigator Award of the Cardiological Society of India, 1986

His prolific academic contributions include 240 published articles

  • Sivasubbu, Sridhar & Scaria, Vinod & Bajaj, Anjali & Mathew, Samatha & Vellarikkal, Shamsudheen & Sivadas, Ambily & Bhoyar, Rahul & Joshi, Kandarp & Jain, Abhinav & Mishra, Anushree & Verma, Ankit & Jayarajan, Rijith & Nalini, Atchayaram & Kumar, A. & Seeralar, Arasar & Gupta, Aayush & Srivastava, Achal & Joshi, Aditi & Sinha, Aditi & Brahmachari, Samir. (2019). Genomics of rare genetic diseases—experiences from India. Human genomics. 14. 10.1186/s40246-019-0215-5. 
  • Talwar, KK & Gupta, Abhinit & Bansal, Raghav & Krishan, Kewal. (2019). High-grade atrioventricular block requiring pacemaker implantation after cardiac transplantation: An unusual complication. International Journal of the Cardiovascular Academy. 5. 29. 10.4103/IJCA.IJCA_28_18. 
  • Guha, Santanu & Sivadasanpillai, Harikrishnan & Ray, Saumitra & Sethi, Rishi & Ramakrishnan, Sivasubramanian & Banerjee, Suvro & Bahl, V.K. & Goswami, Kewal & Banerjee, Amal & Shanmugasundaram, Shobika & Kerkar, Prafulla & Seth, Sandeep & Yadav, Rakesh & Kapoor, Aditya & Mahajan, Ajaykumar & Padinhare, Mohanan & Mishra, Sundeep & Deb, P.K. & Narasimhan, Calambur & Lokhandwala, Yash. (2018). Corrigendum to ‘Cardiological Society of India Position Statement on Management of Heart Failure in India’ [Indian Heart Journal 70S1 (2018) S1–S72]. Indian Heart Journal. 70. 10.1016/j.ihj.2018.11.002. 
  • Kumar, Viveka & Kumar, Vivek & Kumari, Kajal & Talwar, K.K. & Prasad, Divya & Agarwal, Sunil & Yadav, M.S. & Bashir, Hamed & Jatain, Suman & Gupta, S.K.. (2018). Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence. The Egyptian Heart Journal. 70. 10.1016/j.ehj.2018.05.002. 
  • Guha, Santanu & Sivadasanpillai, Harikrishnan & Ray, Saumitra & Sethi, Rishi & Ramakrishnan, Sivasubramanian & Banerjee, Suvro & Bahl, V.K. & Goswami, Kewal & Banerjee, Amal & Shanmugasundaram, Shobika & Kerkar, Prafulla & Seth, Sandeep & Yadav, Rakesh & Kapoor, Aditya & Mahajan, Ajaykumar & Padinhare, Mohanan & Mishra, Sundeep & Deb, P.K. & Narasimhan, Calambur & Lokhandwala, Yash. (2018). CSI Position Statement on Management of Heart Failure in India. Indian Heart Journal. 70 Suppl 1. 10.1016/j.ihj.2018.05.003. 
  • Talwar, KK & Gupta, Abhinit. (2017). Chapter-064 When Should We Consider Automatic Implantable Cardiac Defibrillator after Myocardial Infarction?. 10.5005/jp/books/13035_65. 
  • Iyengar, S & Puri, R & Narasingan, S & Nair, D & Mehta, Vimal & Mohan, J & Wangnoo, S & Dalal, Jamshed & Jha, Vivekanand & Puri, Sonika & Misra, A & Daga, Mradul & Varma, M & Jasuja, Sanjiv & Upadhyaya, S & Kasliwal, R & Bansal, Manish & Mehrotra, Rahul & Jain, A & Ar, A. (2017). Clinical Lipidology Lipid Association of India (LAI) expert consensus statement on management of dyslipidaemia in Indians 2017: part 2 Lipid Association of India (LAI) expert consensus statement on management of dyslipidaemia in Indians 2017: part 2. 
  • Kaur, Rupinder & Das, Reena & Ahluwalia, Jasmina & Kumar, Rohit & Talwar, K.. (2013). Association of Thrombomodulin Gene Polymorphisms and Plasma Thrombomodulin Levels With Acute Myocardial Infarction in North Indian Patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 19. 10.1177/1076029612449900. 
  • Delhi Medical Council
  • Heart Failure Society of India
  • Indian Institute of Science Education and Research, Mohali (IISER)
  • Medical Council of India